Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
2005 · Journal of Neuroinflammation · 369 citations
https://doi.org/10.1186/1742-2094-2-29
T
Thomas Klein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
729
Papers
20.5K
Citations
73
h-index
334
i10-index
Thomas Klein is an academic researcher from Boehringer Ingelheim (Germany). The author has contributed to research in topics: Diabetes Treatment and Management & Legionella and Acanthamoeba research & Cannabis and Cannabinoid Research. The author has an h-index of 73, co-authored 620 publications.
ORCID: 0000-0001-5762-9166Papers by this author
worksFibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
2022 · Cellular and Molecular Gastroenterology and Hepatology · 125 citations
https://doi.org/10.1016/j.jcmgh.2022.12.005
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
2009 · Liver International · 64 citations
https://doi.org/10.1111/j.1478-3231.2010.02264.x
Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy
2022 · Biomedicine & Pharmacotherapy · 61 citations
https://doi.org/10.1016/j.biopha.2022.113947
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
2018 · Acta Neuropathologica Communications · 57 citations
https://doi.org/10.1186/s40478-018-0517-1
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway
2018 · Cardiovascular Diabetology · 57 citations
https://doi.org/10.1186/s12933-018-0702-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat